P
US9322822B2ActiveUtilityPatentIndex 57

Method for detecting asbestos

Assignee: KURODA AKIOPriority: Aug 12, 2011Filed: Aug 9, 2012Granted: Apr 26, 2016
Est. expiryAug 12, 2031(~5.1 yrs left)· nominal 20-yr term from priority
Inventors:KURODA AKIOISHIDA TAKENORINISHIMURA TOMOKI
G01N 21/6458G01N 21/6428G01N 33/5308
57
PatentIndex Score
2
Cited by
17
References
5
Claims

Abstract

In order to provide a method for more efficiently, easily, and accurately detecting asbestos without changing the asbestos detection criterion of the phase-contrast microscope/electron microscope method as compared with the phase-contrast microscope/electron microscope method, a phase-contrast microscope and a fluorescence microscope are used in combination to detect asbestos contained in a test sample after the test sample is made contact with an asbestos-binding protein having a fluorescent label.

Claims

exact text as granted — not AI-modified
The invention claimed is: 
     
       1. A method for detecting asbestos, comprising the steps of:
 a) contacting an asbestos-binding protein complex having a fluorescent label with a test substance; 
 b) detecting a fibrous substance contained in the test substance with use of a phase-contrast/fluorescence microscope in phase-contrast mode, the fibrous substance having a length of 5 μm or more, a width of less than 3 μm, and a length-width ratio of 3:1 or more; and 
 c) determining that the fibrous substance to which the asbestos-binding protein complex is bound is asbestos by detecting, with use of the phase-contrast/fluorescence microscope in fluorescence mode, the asbestos-binding protein complex bound to the fibrous substance detected in step b) based on the fluorescent label; and 
 wherein step b) and step c) are carried out without changing a visual field of the phase-contrast/fluorescence microscope, and 
 wherein the asbestos-binding protein complex comprises four biotin-modified H-NS 60-90  asbestos binding polypeptides and a fluorescently-labeled streptavidin, wherein each of the biotin-modified asbestos binding polypeptides has an amino acid sequence consisting of SEQ ID NO:8 and one biotin molecule at the C-terminus and wherein the biotin-modified asbestos polypeptides bind to the fluorescently-labeled streptavidin through a biotin-streptavidin interaction. 
 
     
     
       2. The method according to  claim 1 , wherein:
 the test substance is collected with use of a filter; 
 the contact between the asbestos-binding protein complex having a fluorescent label and the test substance in step a) occurs on the filter; 
 the method further comprises a transparency step of making the filter transparent by spraying an acetone vapor on the filter after the contacting step a); and wherein 
 step b) is carried out after the transparency step. 
 
     
     
       3. The method according to  claim 1 , wherein steps b) and c) are repeated at least one time. 
     
     
       4. The method according to  claim 2 , wherein:
 the asbestos-binding protein complex binding with the fibrous substance is maintained after the transparency step; and 
 the fluorescent label is one whose fluorescence can be detected by the phase-contrast/fluorescence microscope in fluorescence mode after the transparency step. 
 
     
     
       5. The method according to  claim 4 , wherein the fluorescent label is at least one fluorescent substance selected from the group consisting of Cy3, DyLight488, fluorescein, Alexa488, ATT0488, CF488A, DyLight550 and CF555.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.